Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2012
07/05/2012US20120172369 Inhibitors of diacylglycerol acyltransferase
07/05/2012US20120172364 Rate-controlled particles
07/05/2012US20120172351 Novel fused cyclic compound and use thereof
07/05/2012US20120172348 Sterol derivative
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120171665 Fluorescent markers and use thereof for labeling specific protein targets
07/05/2012US20120170098 Chromene compound
07/05/2012CA2822188A1 New biaryl amide derivatives
07/05/2012CA2821863A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/04/2012EP2471788A1 Novel compound amycolose derivative, and production process and use of same
07/04/2012EP2471787A1 New compounds
07/04/2012EP2471786A1 Aminopyrazole derivative
07/04/2012EP2471774A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471773A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2470527A1 Ether benzotriazole derivatives
07/04/2012EP2470512A1 Aromatase inhibitor
07/04/2012EP2470508A1 Cannabinoid receptor modulators
07/04/2012EP2470183A2 Heterocyclic amide compounds as protein kinase inhibitors
07/04/2012CN1964965B Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
07/04/2012CN1962641B Metalloproteinase inhibitors
07/04/2012CN1832928B 5-membered heterocycle-based p38 kinase inhibitors
07/04/2012CN1668613B Flavone derivatives of inhibitors of cyclin-dependent kinases
07/04/2012CN1248245B Frangible compounds for pathogen inactivation
07/04/2012CN102548986A Aminopyrrolidinone derivatives and uses thereof
07/04/2012CN102548983A Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
07/04/2012CN102548968A Aromatic heterocyclic derivative, and organic electroluminescent element comprising same
07/04/2012CN102532110A Quinazoline derivative and application of serving as cell apoptosis inhibitor
07/04/2012CN102532109A Synthetic method of lapatinib and salt of lapatinib
07/04/2012CN102532088A Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles
07/04/2012CN102532082A 2,2-dimethyl benzopyran compound and preparation method and application thereof
07/04/2012CN102532073A Ethylene derivative serving as selective estrogen receptor modulators (SERMs)
07/04/2012CN102532042A Aryl urea compound as well as intermediate and application thereof
07/04/2012CN102532016A 5-aminoquinoline-2(1H) ketone compound and synthetic method and application thereof
07/04/2012CN102532009A Compounds for inhibiting dipeptidyl peptidase, preparation method for compounds and application of compounds
07/04/2012CN102060851B Method for preparing polyhydroquinolines
07/04/2012CN101932560B Inhibitors for matrix metalloproteinases, pharmaceutical compositions containing them and their uses
07/04/2012CN101735204B Crystalline form III of azimilide dihydrochloride, preparation method and application thereof
07/04/2012CN101687860B Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
07/04/2012CN101654453B Process for the manufacture of the calcium salt of rosuvatatin and crystalline intermediates thereof
07/04/2012CN101511187B Piperidine and piperazine derivatives
07/04/2012CN101506165B Phenyl, pyridine and quinoline derivatives
07/04/2012CN101492444B Nitrogenous heterocyclic compounds with insecticidal activity, preparation and uses thereof
07/04/2012CN101384183B Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
07/03/2012US8212057 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/03/2012US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
07/03/2012US8211932 Organic compounds and their uses
07/03/2012US8211885 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
07/03/2012US8211862 Pharmaceutical compositions comprising crystal forms of 5-azacytidine
07/03/2012CA2564355C Protein kinase modulators and method of use
07/03/2012CA2538405C Novel compounds
07/03/2012CA2529299C Indole derivatives as serotonin reuptake inhibitors
07/03/2012CA2521648C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
07/03/2012CA2509406C Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
07/03/2012CA2504153C Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
07/03/2012CA2488785C Amine compound and use thereof
07/03/2012CA2478526C Substituted aryl ketones
07/03/2012CA2394086C 4-aminopiperidine derivatives and their use as medicine
07/03/2012CA2388818C C-aryl glucoside sglt2 inhibitors and method
06/2012
06/28/2012WO2012087833A1 Hepatitis c inhibitors and uses thereof
06/28/2012WO2012087630A1 Pyridine and pyrimidine compounds for controlling invertebrate
06/28/2012WO2012087237A1 Compounds and their use as bace inhibitors
06/28/2012WO2012087229A1 2-carboxamide-4-piperazinyl-benzofuran derivative
06/28/2012WO2012087174A2 Crystalline forms and processes for their preparation
06/28/2012WO2012086727A1 Novel substituted isoquinoline derivative
06/28/2012WO2012086170A1 Aromatic heterocycle derivative and organic electroluminescent element using same
06/28/2012WO2012085745A1 Glucagon receptor modulators
06/28/2012WO2012085126A1 Oxindolopyrimidine as igf1r receptor inhibitors
06/28/2012WO2012084711A1 N-substituted azetidine derivatives
06/28/2012WO2012083440A1 A process for the preparation of lapatinib and its ditosylate salt
06/28/2012WO2012083436A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
06/28/2012WO2012033374A3 Sulphonate precursor having a 1,2,3-triazolium salt, a production method therefor and an intramolecular nucleophilic fluorination reaction using the same
06/28/2012US20120165519 Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors
06/28/2012US20120165348 Novel compounds
06/28/2012US20120165347 Compounds and their use as BACE Inhibitors
06/28/2012US20120165344 Compounds for the Treatment of Hepatitis C
06/28/2012US20120165339 Cyclopropane derivatives
06/28/2012US20120165338 New biaryl amide derivatives
06/28/2012US20120165327 Spiropiperidines for use as tryptase inhibitors
06/28/2012US20120165322 Rho kinase inhibitors
06/28/2012US20120165318 Heterocyclic compounds for the inhibition of pask
06/28/2012US20120165306 Pyrazinylpyridines useful for the treatment of proliferative diseases
06/28/2012US20120165305 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
06/28/2012US20120165303 Triazolyl phenyl benzenesulfonamides
06/28/2012US20120164102 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
06/28/2012CA2845524A1 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
06/28/2012CA2822923A1 A process for the preparation of lapatinib and its ditosylate salt
06/28/2012CA2822787A1 Novel substituted isoquinoline derivative
06/28/2012CA2822681A1 Crystalline forms and processes for their preparation
06/28/2012CA2822378A1 Compounds and their use as bace inhibitors
06/28/2012CA2822357A1 Hepatitis c inhibitors and uses thereof
06/28/2012CA2822350A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
06/28/2012CA2822080A1 Ectoparasiticidal active substance combinations
06/28/2012CA2822017A1 Glucagon receptor modulators
06/28/2012CA2821480A1 2-carboxamide-4-piperazinyl-benzofuran derivative
06/28/2012CA2819299A1 N-substituted azetidine derivatives
06/27/2012EP2468745A1 Process for the preparation of lapatinib and the salts thereof
06/27/2012EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/27/2012EP2468743A1 Nitrogen-containing bicyclic compounds useful as antibacterial agents
06/27/2012EP2468734A1 Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
06/27/2012EP2468732A1 1H-Quinazoline-2,4-diones
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 694